| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.03 |